Department of Cardiovascular Surgery, Xijing Hospital
Xi'an, Shaanxi, 710032, China
NCT Number: NCT01479049
The investigators previously investigated the cardioprotective effect of an adenosine-lidocaine cardioplegia with moderate-potassium (K+, 10.0 mmol/L) in pediatric cardiac surgery, which was associated with better myocardial protective effects when compared with conventional high-potassium cardioplegia. However, this cardioplegia could not be sucked back into the cardiopulmonary bypass (CPB) circuit because of excessive hemodilution and severe systemic hypotension induced by adenosine. Therefore, the investigators supposed that a moderate-potassium (K+, 10.0 mmol/L) blood cardioplegia without adenosine could also arrest the heart and have better myocardial protective effects compared with conventional hyperkalamic cold blood cardioplegia during cardiac operations without excessive hemodilution and systemic hypotension.
Looking for future studies?
Notify Me1 month–24 month
All sexes
Interventional
Not applicable
Xi'an, Shaanxi, 710032, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hearts were arrested with cold blood cardioplegia with moderate potassium concentration (K+, 10mmol/L)during cardiac operation
Other names: moderate potassium cardioplegia
Hearts are arrested with cold blood cardioplegia with high potassium concentration (K+, 20mmol/L)during cardiac operation.
Other names: High potassium cardioplegia
Time frame: 24h after myocardial reperfusion
myocardial injury could be sensitively reflected by post operative Serum cTnI concentration.
Xijing Hospital
Other
The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery:a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01952171
Cardiovascular Abnormalities, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05902013
Airway Complication of Anesthesia, Cardiovascular Abnormalities
Vienna, State of Vienna, Austria
View Trial DetailsNCT06650787
Cardiovascular Abnormalities, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05524324
Cardiovascular Abnormalities, Cardiovascular Diseases
Caen, France
View Trial Details